bioRxiv Science⌕ Search

bioRxiv · 10.1101/431635

A general-purpose protein design framework based on mining sequence-structure relationships in known protein structures

Abstract

The ability to routinely design functional proteins, in a targeted manner, would have enormous implications for biomedical research and therapeutic development. Computational protein design (CPD) offers the potential to fulfill this need, and though recent years have brought considerable progress in the field, major limitations remain. Current state-of-the-art approaches to CPD aim to capture the determinants of structure from physical principles. While this has led to many successful designs, it does have strong limitations associated with inaccuracies in physical modeling, such that a robust general solution to CPD has yet to be found. Here we propose a fundamentally novel design framework--one based on identifying and applying patterns of sequence-structure compatibility found in known proteins, rather than approximating them from models of inter-atomic interactions. Specifically, we systematically decompose the target structure to be designed into structural building blocks we call TERMs (tertiary motifs) and use rapid structure search against the Protein Data Bank (PDB) to identify sequence patterns associated with each TERM from known protein structures that contain it. These results are then combined to produce a sequence-level pseudo-energy model that can score any sequence for compatibility with the target structure. This model can then be used to extract the optimal-scoring sequence via combinatorial optimization or otherwise sample the sequence space predicted to be well compatible with folding to the target. Here we carry out extensive computational analyses, showing that our method, which we dub dTERMen (design with TERM energies): 1) produces native-like sequences given native crystallographic or NMR backbones, 2) produces sequence-structure compatibility scores that correlate with thermodynamic stability, and 3) is able to predict experimental success of designed sequences generated with other methods, and 4) designs sequences that are found to fold to the desired target by structure prediction more frequently than sequences designed with an atomistic method. As an experimental validation of dTERMen, we perform a total surface redesign of Red Fluorescent Protein mCherry, marking a total of 64 residues as variable. The single sequence identified as optimal by dTERMen harbors 48 mutations relative to mCherry, but nevertheless folds, is monomeric in solution, exhibits similar stability to chemical denaturation as mCherry, and even preserves the fluorescence property. Our results strongly argue that the PDB is now sufficiently large to enable proteins to be designed by using only examples of structural motifs from unrelated proteins. This is highly significant, given that the structural database will only continue to grow, and signals the possibility of a whole host of novel data-driven CPD methods. Because such methods are likely to have orthogonal strengths relative to existing techniques, they could represent an important step towards removing remaining barriers to robust CPD.

Source connections

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Zhou, J., Panaitiu, A. E., Grigoryan, G.. 2018-10-01. A general-purpose protein design framework based on mining sequence-structure relationships in known protein structures. https://doi.org/10.1101/431635

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Engineering and characterisation of AAVS1 FRT cell lines for inducible and dose-dependent gene expression

Investigating biological function with high reproducibility requires the generation of stable cell lines that offer precise and inducible transgene expression. However, traditional methods often suffer from the limitations of random genomic integration, including unpredictable expression levels, leaky basal activity, and disruption of endogenous loci. To address these challenges, we engineered a versatile RPE1 cell line by integrating a TetOn3G-FRT cassette into the AAVS1 safe-harbour locus using CRISPR/Cas9(D10A) nickase. This platform utilises the Flp-FRT recombination system to facilitate rapid, site-specific "plug-and-play" insertion of transgenes, combined with the Tet-On 3G system for tight, dose-dependent expression control. The resulting RPE1 AAVS1 FRT8 line enables highly consistent transgene induction across independent clones, behaving as a monoclonal population. We highlight the importance of rigorous cell line characterisation through a multi-omics approach. Whole genome sequencing identified precise heterozygous integration at the target locus and de novo genomic duplications on other chromosomes. By integrating WGS with high-resolution proteomics and cell cycle analysis, we confirmed that these alterations did not significantly perturb cellular homeostasis or phenotypic fitness. This work establishes a robust and reliable platform for the efficient generation of inducible AAVS1 FRT stable cell lines, facilitating reproducible research in modern molecular biology.

bioengineering↗

Raman-probe-derived biomarkers account for cartilage composition, structure, and viscoelastic properties

Raman spectroscopy is an inelastic light scattering technique that reflects the vibrational modes of the biochemical building blocks of the major constituents that comprise the cartilage extracellular matrix (ECM): glycosaminoglycans (GAG), type-II collagen (COL), and water. We investigated whether ECM-specific biomarkers measured with our recently developed arthroscopy-compatible Raman needle probe characterize the functional viscoelastic properties of articular cartilage explants. Equine osteochondral explants were harvested from high-load (femoral condyle) and low-load (intertrochlear groove) sites to evaluate Raman-derived biomarkers of cartilage structure and function. Viscoelastic material properties (equilibrium/dynamic modulus, phase shift) were determined by mechanical indentation. A computational fibril-reinforced biphasic material model was used to estimate the glycosaminoglycan-associated non-fibrillar-matrix modulus, the collagen-associated fibril-network modulus, and hydraulic permeability. Raman-derived biomarkers enabled evaluation of cartilage tissue composition and structure, accounting for 81% of the variation in GAG content, 53% of the variation in COL content, and 58% of the variation in COL anisotropy. Biomarkers also accounted for 81% of the variation in equilibrium modulus, 58% in dynamic modulus, and 51% in phase shift. For poroelastic properties, biomarkers accounted for 83% of the variation in non-fibrillar-matrix modulus, 25% of the variation in fibril-network modulus, and 34% of the variation in hydraulic permeability. Clinical Significance: Raman spectroscopy provides objective compositional biomarkers that account for viscoelastic material properties underlying articular cartilage function. These findings support its future use as an arthroscopic platform for objective assessment of cartilage injury, monitoring of disease progression, and evaluation of therapeutic interventions.

bioengineering↗

An adjuvant for in vivo CAR-T therapy potentiation against solid tumors

In vivo CAR-T therapy offers rapid and controllable T-cell engineering but has yet to achieve durable efficacy against solid tumors. Rather than focusing solely on CAR-T cells, we harness the intact immune system via an in vivo CAR-T adjuvant (iCTA). Composed of aluminum-manganese hydrogel, iCTA can form a spatially confined antigenic and immunostimulatory niche in-situ. By coupling controlled antigen exposure with STING-type I interferon signaling, iCTA not only recruited and reactivated CAR-T cells, but engage the CAR-negative immunocytes with enhanced dendritic-cell antigen presentation and mobilized endogenous antigen-specific T-cell responses. Combined with mRNA-LNP-mediated in vivo CAR-T generation, a single administration of iCTA increased CAR+ T-cell abundance in draining lymph nodes and blood by 2-fold. It also increased T and NK cell infiltration, established an IFNgamma-enriched tumor microenvironment, and reduced exhaustion-associated T-cell states. iCTA improved tumor regression and survival, establishing an adjuvant strategy to enhance in vivo CAR-T therapy.

bioengineering↗